Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

GODAVARI DRU vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 GODAVARI DRU   ACTAVIS
EQUITY SHARE DATA
    GODAVARI DRU
Mar-23
ACTAVIS
Dec-18
GODAVARI DRU/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs10216,126-   
Low Rs5210,818-   
Sales per share (Unadj.) Rs212.03,955.8-  
Earnings per share (Unadj.) Rs5.0-1,274.2-  
Cash flow per share (Unadj.) Rs7.6416.9-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs44.416,315.7-  
Shares outstanding (eoy) m7.53332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x0.43.4 10.7%   
Avg P/E ratio x15.3-10.6 -144.9%  
P/CF ratio (eoy) x10.132.3 31.3%  
Price / Book Value ratio x1.70.8 210.1%  
Dividend payout %00-   
Avg Mkt Cap Rs m5804,480,758 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m480-   
Avg. sales/employee Rs Th077,851.4-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,076.0-  
INCOME DATA
Net Sales Rs m1,5961,315,689 0.1%  
Other income Rs m725,160 0.0%   
Total revenues Rs m1,6031,340,849 0.1%   
Gross profit Rs m10234,478 0.3%  
Depreciation Rs m19562,428 0.0%   
Interest Rs m3975,923 0.1%   
Profit before tax Rs m49-578,713 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,595 0.0%   
Tax Rs m11-7,334 -0.2%   
Profit after tax Rs m38-423,784 -0.0%  
Gross profit margin %6.42.6 242.7%  
Effective tax rate %23.31.3 1,837.1%   
Net profit margin %2.4-32.2 -7.4%  
BALANCE SHEET DATA
Current assets Rs m870539,627 0.2%   
Current liabilities Rs m737477,372 0.2%   
Net working cap to sales %8.34.7 176.1%  
Current ratio x1.21.1 104.4%  
Inventory Days Days120 5.2%  
Debtors Days Days1,32566 1,997.8%  
Net fixed assets Rs m344148,929 0.2%   
Share capital Rs m750-   
"Free" reserves Rs m2590-   
Net worth Rs m3345,426,601 0.0%   
Long term debt Rs m1191,910,903 0.0%   
Total assets Rs m1,2148,483,012 0.0%  
Interest coverage x2.3-6.6 -34.1%   
Debt to equity ratio x0.40.4 101.5%  
Sales to assets ratio x1.30.2 847.5%   
Return on assets %6.4-4.1 -154.9%  
Return on equity %11.3-7.8 -145.1%  
Return on capital %19.5-4.8 -403.5%  
Exports to sales %0.40-   
Imports to sales %60.30-   
Net fx Rs m-9560-   
CASH FLOW
From Operations Rs m132470,046 0.0%  
From Investments Rs m-86258,229 -0.0%  
From Financial Activity Rs m-38-806,740 0.0%  
Net Cashflow Rs m8-78,073 -0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare GODAVARI DRU With: ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  

Compare GODAVARI DRU With: ALPA LAB  MARKSANS PHARMA.  PARENT.DRUGS  WALPAR NUTRITIONS LTD.  BIOCON   



Today's Market

Gift Nifty Up 25 Points | Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today Gift Nifty Up 25 Points | Tech Mahindra Q4 Results | ACC Declares Interim Dividend | Top Buzzing Stocks Today(Pre-Open)

Indian share markets continued the momentum as the session progressed and ended the higher.